- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Emergent Biosolutions is a drug manufacturers - specialty & generic business based in the US. Emergent Biosolutions shares (EBS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $8.10 – a decrease of 4.48% over the previous week. Emergent Biosolutions employs 1,600 staff and has a trailing 12-month revenue of around $1.1 billion.
What's in this guide?
Our top picks for where to buy Emergent Biosolutions stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Emergent Biosolutions stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EBS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Emergent Biosolutions stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Emergent Biosolutions stock price (NYSE: EBS)
Use our graph to track the performance of EBS stocks over time.Emergent Biosolutions shares at a glance
Information last updated 2024-12-15.
| Latest market close | $8.10 |
|---|---|
| 52-week range | $1.42 - $15.10 |
| 50-day moving average | $8.63 |
| 200-day moving average | $6.26 |
| Wall St. target price | $12.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-11.22 |
Is it a good time to buy Emergent Biosolutions stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Emergent Biosolutions price performance over time
Historical closes compared with the close of $8.06 from 2024-12-19
| 1 week (2024-12-13) | -4.95% |
|---|---|
| 1 month (2024-11-21) | -14.26% |
| 3 months (2024-09-20) | 23.05% |
| 6 months (2024-06-20) | 24.57% |
| 1 year (2023-12-20) | 261.43% |
|---|---|
| 2 years (2022-12-20) | -29.48% |
| 3 years (2021-12-20) | 44.36 |
| 5 years (2019-12-20) | 54.42 |
Is Emergent Biosolutions stock undervalued or overvalued?
Valuing Emergent Biosolutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Emergent Biosolutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Emergent Biosolutions's PEG ratio
Emergent Biosolutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.55. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Emergent Biosolutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Emergent Biosolutions financials
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 24.51% |
| Gross profit TTM | $290.1 million |
| Return on assets TTM | -4.22% |
| Return on equity TTM | -34.64% |
| Profit margin | -18.55% |
| Book value | $9.40 |
| Market Capitalization | $540.2 million |
TTM: trailing 12 months
Emergent Biosolutions share dividends
We're not expecting Emergent Biosolutions to pay a dividend over the next 12 months.
Emergent Biosolutions share price volatility
Over the last 12 months, Emergent Biosolutions's shares have ranged in value from as little as $1.42 up to $15.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Emergent Biosolutions's is 1.574. This would suggest that Emergent Biosolutions's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Emergent Biosolutions overview
Emergent BioSolutions Inc. , a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Frequently asked questions
What percentage of Emergent Biosolutions is owned by insiders or institutions?Currently 2.153% of Emergent Biosolutions shares are held by insiders and 57.787% by institutions. How many people work for Emergent Biosolutions?
Latest data suggests 1,600 work at Emergent Biosolutions. When does the fiscal year end for Emergent Biosolutions?
Emergent Biosolutions's fiscal year ends in December. Where is Emergent Biosolutions based?
Emergent Biosolutions's address is: 400 Professional Drive, Gaithersburg, MD, United States, 20879 What is Emergent Biosolutions's ISIN number?
Emergent Biosolutions's international securities identification number is: US29089Q1058 What is Emergent Biosolutions's CUSIP number?
Emergent Biosolutions's Committee on Uniform Securities Identification Procedures number is: 29089Q105
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question